Submit Manuscript now
Impact Factor 4.452

admin

The Use of Inhalational Nitrous Oxide (Entonox) As The Sole Analgesic Agent During Colonoscopy is Feasible and Efficacious in a Substantial Proportion of Patients: A Review of a Surgeon’s Experience

Leave a Comment / Volume 6 / By

1. Abstract 1.1. Objective: Colonoscopy is associated with significant discomfort requiring administration of intravenous (IV) sedation and analgesia. Nitrous Oxide (Entonox) has been shown as an alternative analgesic modality but is less frequently used in practice. This study examined the efficacy and applicability of Entonox as sole analgesic agent during colonoscopy. DOI:http://dx.doi.org/10.47829/JJGH.2021.62202

Synthesis, Characterization, Biological Evaluation of Some Heterocyclic Oxazepine Derivatives

Leave a Comment / Volume 6 / By

1. Abstract The new serious of pentyloxy and aryloxy benzaldehyde (3ae) were synthesized from the substitution reaction of 4-hydroxy benzaldehyde with different aryl bromide and alkyl bromide, on the basis of Williamson ether synthesis in the presence of Potassium carbonate using absolute ethanol as a solvent. The second step was the synthesis of 2-amino-5-(p-tolyl)1,3,4-thiadiazole. DOI:http://dx.doi.org/10.47829/JJGH.2021.62201

Mixing of Sputnik V and Astrazeneca COVID-19 Vaccines

Leave a Comment / Volume 6 / By

1. Abstract The coronavirus disease 2019 (COVID-19) vaccine helps to develop immunity to SARS-CoV-2, the virus that causes COVID-19, in most cases preventing the disease. Although various brands of vaccines work in different modes, all COVID-19 vaccines prompt an immune reaction to make the body remembers how to protect from the virus in the future. …

Mixing of Sputnik V and Astrazeneca COVID-19 Vaccines Read More »

Epidemiology of Hepatocellular Carcinoma (HCC) In Tertiary Level Hospitals in Bangladesh

Leave a Comment / Volume 6 / By

1. Abstract HCC is the most common primary liver malignancy and cause of cancer-related death worldwide including Bangladesh. It occurs more often in males than females. The incidence of HCC continues to escalate due to HBV, HCV infection, non-alcoholic fatty liver disease (NAFLD). HBV and HCV are also important etiological factors for developing chronic liver …

Epidemiology of Hepatocellular Carcinoma (HCC) In Tertiary Level Hospitals in Bangladesh Read More »

Hydrocolonic Sonography. A Forgotten Technique

Leave a Comment / Volume 6 / By

1. Abstract 1.1. Objectives: Study of the sensitivity of Hydrocolonic Sonography (HS) in the detection of colonic lesions and how hydrocolonic sonography with echographic contrast agent (HSEC) can improve this technique. Hydrocolonic sonograhpy with ultrasound contrast (dual system), of a malignant polyp in sigmoid colon. On the left half of the video, we can observe a …

Hydrocolonic Sonography. A Forgotten Technique Read More »

Increased Expression of GNL3L is Associated with Aggressive Phenotypes in Colorectal Cancer

Leave a Comment / Issue 1 Article, Volume 6 / By

1. Abstract 1.1. Background and Objective: Guanine nucleotide binding protein-like 3-like (GNL3L) plays critical roles in development and progression of several types of human cancers. However, the function and clinical significance of GNL3L in colorectal cancer (CRC) remain unclear. In this study, the effect of GNL3L in CRC and its underlying mechanism were investigated. DOI:http://dx.doi.org/10.47829/JJGH.2021.62103

Review of Esophagectomy Side Effects

Leave a Comment / Issue 1 Article, Volume 6 / By

1. Abstract The primary indication for an esophagectomy is esophageal cancer or Barrett’s esophagus with high-grade dysplasia. Patients undergoing esophagectomy often present with dysphagia, side effects from chemotherapy, decreased appetite, and weight loss. Esophagectomy may be an operation involving the abdomen, neck, and/or chest requiring 5 to 7 days of NPO status to permit healing …

Review of Esophagectomy Side Effects Read More »

Need of Dual Antiviral Treatment in Chronic Hepatitis B

Leave a Comment / Issue 1 Article, Volume 6 / By

1. Abstract 1.1. Introduction: Approximately one third of the world’s population has serological evidence of past or present infection with the hepatitis B virus (HBV). An estimated 350-400 million people are surface HBV antigen (HBsAg) carriers. India has 40 million HBV carriers i.e. 10–15% share of total pool of HBV carriers of the world. In …

Need of Dual Antiviral Treatment in Chronic Hepatitis B Read More »

What Our Author Say's

I am glad that I found this platform. It was easy to get my research published and I was guided at every step. I highly recommend them.
Shuang-Qin Yi
am grateful to the Japanese Journal of Gastroenterology and Hepatology for helping me with my research and publishing it. Looking forward to more work with them.
Makki Fayadh
It has been a pleasure working with the Japanese Journal of Gastroenterology and Hepatology. They have been amazing in helping me with my manuscript
Han Min
I am glad that I submitted my manuscript here. They helped me make necessary edits and published the best version of it. I highly recommend them.
Sadaf Saleem

FAQ's About Jajgastrohepto

The Japanese Journal of Gastroenterology and Hepatology accepts all kinds of manuscripts, such as research, studies, reviews, clinical images, editorials, commentaries, etc.

For Detailed quotations reach out submission@jajogh.jp

It depends on the length of the manuscript and the reviews and edits needed.

We will help you with as many reviews and edits as are required to make your manuscript perfect for publication.

A good impact factor for JJGH is 2.0 as per Journal Citations Reports of 2021.

Niigata, 7F Stork Building Kagamibashi, 1230-7, 7-bancho, Kamiookawamaedori, Chuo-ku, Niigata, 951-8068, Japan.

*2021 Journal unofficial Impact Factor was established by dividing the number of articles published in 2020 with the number of times they are cited in 2021 based on Google Scholar Citation Index database. If ‘X’ is the total number of articles published in 2020 and ‘Y’ is the number of times these articles were cited in indexed journals during 2021 then, journal impact factor = Y/X.

Copyright 2018-2024 All Rights Reserved.